How household batteries overcome energy transition obstacles
Household solar batteries could be the solution to overcome high costs and community opposition in Australia's renewable energy transition.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
ABC News
an hour ago
- ABC News
Health practitioner regulator gets tough on cosmetic injectable industry to protect patient safety
The Australian health practitioner regulator has introduced sweeping new guidelines for dentists and nurses performing non-surgical cosmetic injectable procedures, in a bid to better protect the public from players putting profits ahead of patient safety. The new rules released by the Australian Health Practitioner Regulation Agency (AHPRA) today mandate further education and training before healthcare practitioners can perform cosmetic procedures like botox and filler injections. They also introduce minimum periods of experience required for nurses wanting to work with injectables. Nurses and dentists have been operating in the billion dollar cosmetic injectable industry for years without being required to undertake any formal additional education or training, before injecting patients with neurotoxins like botox. While many have become highly skilled at the practice, there's concern clearer rules are needed for those wanting to enter the industry to ensure they have enough training. Under the changes, advertisements will be required to include the details of the registered practitioner performing the procedures. Testimonials from social media influencers will be banned, along with targeted advertising of cosmetic procedures to minors. AHPRA CEO Justin Untersteiner said not all cosmetic injectors would be happy with the tighter rules and expected some would choose to leave the industry under the changes. "There will be others who have to modify their business models, and modify their practices to meet these guidelines," he said. Nurses and dentists have until September to prepare for the changes and ensure they are compliant with the new guidelines, which align with those already in place for doctors. "[After that] we will be identifying those that are doing the wrong thing and we will take action where we need to," he said. There's been a recent spate of cases of non-registered practitioners and clinics using off-brand or out-of-date dermal fillers and botox on patients leading to multiple hospitalisations after patients became ill with botulism. The NSW Health Care Complaints Commission (HCCC) warned patients of a Sydney cosmetic clinic to be tested for blood borne viruses after finding evidence that non-registered staff were injecting patients with dermal fillers and botox. The new federal guidelines are the latest salvo from state and federal regulators, who have been cracking down on cosmetic injectable providers, throwing some clinics into chaos as they scramble to ensure they comply with regulations. Many injectable businesses around the country are run by nurses who do the injecting, and often hold supplies of prescription fillers and anti-wrinkle injections like botox on site, and arrange telehealth consults for their patients so doctors can remotely prescribe the products. Recent guidance released in Queensland has made it clear the practice isn't legal unless the nurse is a Nurse Practitioner with prescribing rights and additional qualifications, or there's a doctor on site. State pharmaceutical and poisons regulators in both NSW and Queensland have also been conducting compliance checks on clinics, monitoring the possession and storage of schedule 4 medications like botox and fillers. AHPRA said it was concerned some telehealth practitioners weren't meeting their professional obligations, after media reports revealed patients were sometimes being issued botox scripts in less than a minute. The new guidance from AHPRA reinforced practitioners were responsible for understanding relevant state and federal drugs and poisons laws, and that those who prescribed cosmetic injectables were still responsible for the patients, regardless of whether or not they performed the procedure. The guidelines also mandate written information must be given to the patient, including the health practitioner who prescribed the cosmetic injectable, the practitioner who performed the procedure, details of the products used, what aftercare was needed, and who is responsible for coordinating the patient's care. From September, nurses will be required to complete a set period of 12 months of full-time practice before expanding their scope to include non-surgical cosmetic procedures. The guidelines state further education will be necessary for those practitioners wanting to work with cosmetic injectables. Those practitioners will need training in anatomy and physiology, education in assessing patients for suitability for the procedure, and both theoretical and hands-on training in the specific procedure being offered. While AHPRA CEO Justin Untersteiner said there had always been an obligation for practitioners to ensure they had appropriate skills, the new rules were "really making it crystal clear" about what it expected for those sorts of procedures. "That will likely require specific training around facial anatomy or physiology and I can tell you that is not a weekend course, this is proper training that will be required," Mr Untersteiner said. He said the regulator had heard multiple cases of permanent irreversible facial nerve damage as well as potentially life-threatening strokes from cosmetic injectables. "All registered health practitioners are responsible for ensuring they are sufficiently educated, trained and competent to safely undertake any cosmetic procedure they may perform." Do you have a story to share? Email Nursing and Midwifery Board of Australia chair, Veronica Casey, welcomed the new guidelines and said the safety of the Australian public was paramount. "These types of procedures are undertaken every day and can have serious consequences if not done correctly," she said. The new AHPRA regulations outline that "registered health practitioners must also disclose any financial interests that could be perceived as influencing the advice they provide to people about cosmetic procedures". Some doctors and nurses working in cosmetic injectable clinics operate on commission-based models, meaning the more work done or greater the volume of product injected, the more money they stand to make from a consultation. But whether commission-based models need to be disclosed to patients will be subject to clinician's judgement and assessed by the regulator on a "case-by-case basis". It is illegal to advertise almost all prescription medications or related services including cosmetic injectables, with the Therapeutic Goods Administration (TGA) responsible for regulation. Despite this, cosmetic clinics have been widely flouting advertising rules for years on social media and their own websites. The TGA said it had recently sent around 100 "targeted guidance letters" to providers in the cosmetic injectables industry, following identification of alleged non-compliance and that more will follow "in the coming weeks". The agency said in a statement that last financial year it submitted over 12,000 requests for removal to social media platforms over the alleged unlawful advertising of therapeutic goods, including "over 2,500 advertisements relating to cosmetic injectable products". The AHPRA guidelines now state any imagery used in advertising of higher-risk cosmetic procedures must be focused on information or education, citing concerns advertising was promoting the "trivialization and glamourisation" of cosmetic procedures to vulnerable patients, especially on social media. Examples of features more likely to be considered entertainment included imagery like music, dancing, singing, or comedic comments. It comes almost four years after a joint ABC and Sydney Morning Herald investigation revealed a shocking video of two doctors dancing while performing liposuction on an unconscious patient, which led to a crackdown on the cosmetic surgery industry. Under the new injectables guidelines there will be a total ban on targeted advertising towards patients under 18, as well as a mandatory seven-day cooling off period between the first consultation and any procedures for minors. Patients considering cosmetic injectables have been encouraged to check if a health practitioner is registered on the Australian Health Practitioners Regulation Agency website.
News.com.au
an hour ago
- News.com.au
ASX May Winners: No walking away in May for Dateline Resources, which rocketed 978pc
Australia's S&P/ASX 200 rallied 4.20% in May along with global markets as US-tariff tensions eased All of 11 sectors gained in May, led by tech up almost 20% followed by energy and communication services Dateline Resources surged 978% in May with its gold and rare earths Colosseum project in California getting a shoutout from US President Donald Trump The Aussie bourse joined global equities to rally for the second consecutive month in May, driven by relief from US tariff-related risk, according to S&P Dow Jones Indices (S&P DJI). Australia's S&P/ASX 200 rose 4.20% in May and is up 4.95% YTD, in what has been a volatile year for equity markets. Smaller stocks outperformed larger caps in May, with the S&P/ASX Small Ordinaries climbing 5.76%. Fears around escalating US tariffs eased in May bringing relief to global markets. Investor sentiment improved as trade tensions between the US and China showed signs of de-escalation, with diplomatic rhetoric softening. Starting May 14, the US reduced tariffs on Chinese imports from as high as 145% to 30%, while China lowered its tariffs on US goods from 125% to 10%. The agreement aimed to create a window for further negotiations. However, by the end of May Trump was accusing China of breaking the tariff truce and China responded with accusations of American misconduct, reigniting concerns of trade war between the world's two largest economies. May also saw legal challenges to existing US tariffs gain momentum. Several US courts began reviewing cases contesting the legality of specific tariffs imposed, signalling that some could be rolled back or revised. Back at home the Reserve Bank of Australia board announced on May 20 that it had decided to lower the cash rate by 25 basis points to 3.85% as inflation fell to within the central bank's 2-3% target range. Trimmed mean inflation, the RBA's preferred measure of underlying inflation, was 2.9% over the year to the March quarter. However, the RBA said it was continuing to manage expectations for future interest rate cuts, pointing to ongoing uncertainty around tariffs and the domestic labour market. "The Monetary Policy Board judged that the risks to inflation had become more balanced but that the outlook is uncertain and depends heavily on unpredictable developments in global trade policy," the RBA said. Tech tops winning sectors All sectors within the S&P/ASX 200 posted gains in May, led by Information Technology, which was up 20%, followed by Energy, up 9%. Defensive sectors including Utilities, Consumer Staples and Health Care ended May in the green but were the month's underperformers. Factor indices in positive territory, while fix income mixed All reported Australian factor indices remained in positive territory in May with Momentum – the best-performing factor in 2024 – outperforming along with Equal Weight, and Growth. S&P DJI said High Dividend and Value trailed, consistent with the trends observed at the sectoral level. Volatility declined across the board, with Australia's S&P/ASX 200 VIX falling to a 10-handle and the US VIX dropping below 20 – both lower than levels seen prior to US President Donald Trump's Liberation Day tariff announcement on April 2. Fixed income indices were mixed as long-term rates remained volatile globally. The 50 best performing ASX stocks in May CODE COMPANY LAST SHARE PRICE MAY RETURN % MARKET CAP DTR Dateline Resources 0.097 978% $262,956,021 RMI Resource Mining Corp 0.028 460% $21,299,147 RPG Raptis Group Limited 0.038 389% $6,136,985 LKY Locksley Resources 0.08 321% $9,680,000 EDE Eden Innovations 0.003 200% $12,329,643 SMM Somerset Minerals 0.024 140% $9,722,874 PUA Peak Minerals Ltd 0.021 133% $56,146,426 OCN Oceana lithium 0.059 119% $7,837,294 MKL Mighty Kingdom Ltd 0.013 117% $5,347,559 RML Resolution Minerals 0.017 113% $7,361,016 LOC Locate Technologies 0.115 109% $14,083,568 PEK Peak Rare Earths Ltd 0.255 108% $89,789,736 HRE Heavy Rare Earths 0.041 105% $8,529,389 FRS Forrestania Resources 0.079 103% $25,772,734 DVL Dorsavi Ltd 0.014 100% $9,506,093 HIO Hawsons Iron Ltd 0.026 100% $25,412,534 LLI Loyal Lithium Ltd 0.13 97% $13,095,298 4DS 4Ds Memory Limited 0.059 97% $126,146,384 NWC New World Resources 0.047 96% $168,210,882 EDU EDU Holdings Limited 0.27 93% $42,154,954 TMG Trigg Minerals Ltd 0.081 88% $75,757,331 MM1 Midas Minerals 0.28 87% $38,837,399 MPW Metal Powdworks Ltd 0.875 86% $81,567,403 VTM Victory Metals Ltd 0.88 85% $101,837,524 SPD Southern Palladium 0.415 84% $35,470,500 BTM Breakthrough Minerals 0.125 84% $5,264,545 ELS Elsight Ltd 0.77 83% $123,584,023 VRL Verity Resources 0.029 81% $7,742,283 YAR Yari Minerals Ltd 0.009 80% $4,992,403 D3E D3 Energy Limited 0.115 80% $10,331,751 RNT Limited 0.032 78% $24,735,277 MEG Megado Minerals Ltd 0.014 75% $5,875,566 G50 G50Corp Ltd 0.19 73% $28,907,579 CDT Castle Minerals 0.1 72% $11,020,909 CDR Codrus Minerals Ltd 0.034 70% $6,822,235 RLT Renergen Limited 0.96 70% $28,051,528 CCE Carnegie Cln Energy 0.061 69% $20,873,598 ERD Eroad Limited 1.39 67% $253,004,353 TAS Tasman Resources Ltd 0.025 67% $3,314,567 BMR Ballymore Resources 0.165 65% $27,393,241 FML Focus Minerals Ltd 0.385 60% $101,728,319 ANX Anax Metals Ltd 0.008 60% $7,062,461 JAL Jameson Resources 0.04 60% $23,207,866 MGU Magnum Mining & Exp 0.008 60% $7,851,556 WTM Waratah Minerals Ltd 0.32 60% $74,723,925 NYR Nyrada Inc 0.165 57% $32,692,141 ESK Etherstack PLC 0.44 57% $58,155,681 STK Strickland Metals 0.145 56% $316,730,372 PPY Papyrus Australia 0.014 56% $8,590,226 FG1 Flynn Gold 0.031 55% $11,348,178 Dateline Resources (ASX:DTR) rose a staggering 978% in May, reaching a market cap of ~$262 million with much of the investor interest sparked by a shoutout from Trump on his social media platform Truth Social. DTR owns the 1.1Moz Colosseum gold project in California, with Trump highlighting its rare earths potential given its close proximity to the Mountain Pass rare earths mine. The company also announced an updated scoping study with little changed except an assumed gold price moving from US$2200/oz to US$2900/oz, still well below spot. Annual gold production remains at 71,000ozpa, but net revenue before tax is projected to jump 208%, from US$398m to US$827 million. The internal rate of return before tax – a measure of profitability – climbs from 31% to 61%, while pre-tax discounted cashflow rises 234% to US$550m. DTR was up another ~50% on Monday after painting more details on upcoming field work and drilling to find new sources of gold and rare earths at Colosseum. Resource Mining Corporation (ASX:RMI) saw its share price surge 460% in May, driven by a series of exploration updates from its Mpanda copper-gold project in Tanzania. The share climb triggered an ASX price and volume query on May 16. The company also announced it had received firm commitments from professional and sophisticated investors for a placement to raise $2m. Locksley Resources (ASX:LKY) also had a strong May up 321% in what Kristie Batten described as a "transformational month" for the company thanks to its Mojave rare earth and antimony project in California. Geologist Allister Caird joined the company in May as Head of Critical Minerals, while Donald Trump's push to boost local mineral production is seen as a major tailwind for LKY. Its Mojave project is located just 1.4km from MP Materials' Mountain Pass mine — the only producing rare earths mine in the US. LKY closed more than 30% higher on Monday with its share price ~1.8 cents at the start of May and now 10.5 cents. Eden Innovations (ASX:EDE) was up 200% in May after issuing a positive update on sales of its EdenCrete Pz7 concrete additive, a product that makes standard concrete mixes stronger and reduces the need for carbon-intensive Portland Cement. Over the past three months, EDE said sales topped US$567k. In April and May sales were 86% higher than the whole of Q4 FY24. EDE said it had experienced rapid growth in sales of Pz7 for commercial applications in the US, Ecuador, Mexico, and Canada. The 50 worst performing ASX stocks in May CODE COMPANY LAST SHARE PRICE MAY RETURN % MARKET CAP LSR Lodestar Minerals 0.006 -65% $2,069,755 DUB Dubber Corp Ltd 0.016 -62% $41,973,880 OSL Oncosil Medical 0.002 -56% $13,819,747 HCF H&G High Conviction 0.025 -55% $504,568 CRN Coronado Global Resources 0.11 -51% $209,556,716 1TT Thrive Tribe Tech 0.001 -50% $2,031,723 BMO Bastion Minerals 0.0015 -50% $1,807,255 E79 E79 Gold Mines 0.018 -50% $2,693,015 JAY Jayride Group 0.001 -50% $1,427,889 LNR Lanthanein Resources 0.001 -50% $2,443,636 SHP South Harz Potash 0.003 -50% $3,308,186 88E 88 Energy Ltd 0.026 -48% $27,776,410 AON Apollo Minerals Ltd 0.009 -47% $9,284,569 AR3 Austrare 0.058 -41% $12,931,229 CAE Cannindah Resources 0.032 -41% $23,298,558 1AD Adalta Limited 0.003 -40% $1,286,446 AVH Avita Medical 1.86 -40% $136,757,000 FTC Fintech Chain Ltd 0.003 -40% $1,952,309 OLH Oldfields Holdings 0.027 -40% $5,752,597 IMU Imugene Limited 0.015 -40% $119,472,333 NUF Nufarm Limited 2.38 -40% $896,180,426 ARN Aldoro Resources 0.32 -38% $56,058,088 ENL Enlitic Inc 0.03 -38% $24,527,901 IVT Inventis Limited 0.01 -38% $764,244 KLI Killi Resources 0.03 -38% $4,346,936 RNX Renegade Exploration 0.0025 -38% $2,576,727 OFX OFX Group Ltd 0.72 -36% $178,338,490 IR1 Irismetals 0.1 -35% $18,970,532 CCM Cadoux Limited 0.033 -35% $12,982,116 NHE Noble Helium 0.011 -35% $5,395,725 DTZ Dotz Nano Ltd 0.048 -34% $28,323,086 BDM Burgundy D Mines Ltd 0.025 -34% $38,375,971 3DP Pointerra Limited 0.055 -34% $44,279,224 AQX Alice Queen Ltd 0.004 -33% $4,998,560 AVD Avada Group Limited 0.2 -33% $18,261,030 AXP AXP Energy Ltd 0.001 -33% $6,684,681 DMG Dragon Mountain Gold 0.004 -33% $1,578,687 EG1 Evergreen Lithium 0.032 -33% $6,587,349 KPO Kalina Power Limited 0.004 -33% $17,597,818 MOM Moab Minerals Ltd 0.001 -33% $1,733,666 RAN Range International 0.002 -33% $1,878,581 RAS Ragusa Minerals Ltd 0.014 -33% $1,996,383 REZ Resources & Energy Group 0.016 -33% $12,089,504 VML Vital Metals Limited 0.002 -33% $11,790,134 REE Rarex Limited 0.019 -32% $16,562,952 PFT Pure Foods Tas Ltd 0.015 -32% $2,166,810 EWC Energy World Corporation 0.015 -32% $49,262,740 KEY KEY Petroleum 0.041 -32% $1,008,640 SRJ SRJ Technologies 0.013 -32% $9,083,671 TEE Topend Energy 0.052 -32% $14,243,344
News.com.au
an hour ago
- News.com.au
Five in play as dream builders sniff the potential of 1950s home
Five bidders raised their hands for a 1950s brick house in Newtown amid a further indicator of improving buyer sentiment in the property market. The three-bedroom house at 8 Garlick Ave was snapped up for $820,000, selling for $70,000 above the 525sq m property's reserve price. McGrath Geelong agent David Cortous said the broad field of interest in the property underlined the improving conditions for sellers following a second interest-rate cut in May. 'There was interest of quite a few different buyers,' Mr Cortous said. 'There was first-home buyers, there was families that were going to come there and love, renovate and maybe do some type of extension. 'And there was actually two that were looking for a project – to do it up and then re-sell it. 'That was the buyer in the end.' Mr Cortous said part of the attraction was the property's location, on a street opposite the Geelong College Junior School and near Elderslie Reserve. But the property had a lot to offer for a renovator, or redeveloper. 'It was a 1950s brick, so it had a bit of charm to it and it was very much a blank canvas,' he said. 'It really, really neat but very much a blank canvas.' Mr Cortous said the property offered possibilities for different buyer groups. 'It would be a good property to hold for an investor, a good property for a family to get in and live there for the next few years as set up home.' There was plenty of original charm apparent in the house, including the kitchen and central bathroom. The property last sold for $65,000 in 1987 and had been rented since 2008. It was one of three properties taken to auction to sell in Newtown at the weekend, including a three-bedroom weatherboard house that also offered buyers to chance to renovate or redevelop. A property at 4 Coronal Ave, Newtown, sold for $790,000, which was at the top of its quoted range. HF Richardson, Newtown agent Tony Hyde said a local builder, acting on behalf of a Sydney investors, secured the home as a potential renovation or rebuild. Mr Hyde said the property passed in at $760,000 after the one bidder emerged for the property. Several first-home buyers were keen, but were unable to bid at auction, he said. 'They'll be looking at either renovating the existing house or rebuilding,' Mr Hyde said. 'It's such a well-held area, a lot of people don't know that it's a Newtown area. 'It's close to schools, you've got the Geelong College Junior and Middle Schools around the corner and it's just off Aberdeen St, so it's close to the ring road and the shopping centres and it's all flat, easy walking.' The much-loved family home offers has great scope to value-add through a renovation, rebuild or a development on the 613sq m block. A favourable north-facing rear orientation with established gardens and a lush lawn adding to the overall appeal of the property. A rare 1146sq m vacant block at 3-5 Stinton Ave, Newtown was snapped up for $1.882m in the biggest sale reported in the past week.
